Page 1 | Search Results | Blood | American Society of Hematology

1-19 of 19

Sort by

Sort Order Select

Journal Articles

Peripheral Blood Cytopenia and Subsequent Risk of Cardiovascular Disease and Mortality

Radhika Gangaraju, MD, Insu Koh, PhD, Marguerite R. Irvin, PhD, Leslie A. Lange, PhD, Damon E. Houghton, MDMS, Diego A Herrera, MD, Monika Safford, MD, Mary Cushman, MD, Smita Bhatia, MDMPH, Neil A. Zakai, MDMSc

Blood (2019) 134 (Supplement_1): 5002.

https://doi.org/10.1182/blood-2019-125956

Published: 2019

Journal Articles

Arterial Occlusive Events in Chronic Myeloid Leukemia Patients Treated with Ponatinib in the Real-Life Practice: Prophylaxis and Identification of Risk Factors

Blood (2018) 132 (Supplement 1): 3006.

https://doi.org/10.1182/blood-2018-99-111502

Published: 2018

Journal Articles

Hemoglobin Levels, Sex, Race and Coronary Heart Disease Risk in the Reasons for Geographic and Racial Differences in Stroke Study

Damon E. Houghton, MD MSc, Alicia Ellis, PhD, Mary Cushman, MD, Daniel Douce, MD, Nigel S. Key, MBChB, FRCP, Monika Safford, MD, George Howard, DrPH, Neil A Zakai, MDMSc

Blood (2017) 130 (Supplement 1): 4737.

https://doi.org/10.1182/blood.V130.Suppl_1.4737.4737

Published: 2017

Journal Articles

Association of Comprehensive Lipoprotein Profiling with Coronary Artery Disease in Allogeneic Stem Cell Transplant (Allo-SCT) Survivors

Upneet Chawla, BS, MD, Maureen Sampson, MT, Natasha A Jain, MD, Prathima Anandi, MD, Sawa Ito, MD PhD, Eleftheria Koklanaris, RN, Pawel Muranski, MD, John Barrett, MD, Marcus Y Chen, MD, Alan Remaley, MD PhD, Minoo Battiwalla, MDMS

Blood (2016) 128 (22): 828.

https://doi.org/10.1182/blood.V128.22.828.828

Published: 2016

Journal Articles

Association of Sickle Cell Trait with Risk of Coronary Heart Disease in African Americans

Blood (2016) 128 (22): 11.

https://doi.org/10.1182/blood.V128.22.11.11

Published: 2016

Journal Articles

Distinct Clinical, Laboratory, and Molecular Features of Myeloproliferative Neoplasm Patients Presenting with Splanchnic Vein Thrombosis

Joan How, MD, Stephen T. Oh, MDPhD, Kathryn M. Trinkaus

Blood (2016) 128 (22): 3121.

https://doi.org/10.1182/blood.V128.22.3121.3121

Published: 2016

Journal Articles

Elevated Interleukin-10 and “Disappearing HDL Syndrome” in Lymphoproliferative Disorders

Andreas Moriaitis, MD, Lita Freeman, PhD, Robert Shamburek, MD, Robert Wesley, PhD, Wyndham H. Wilson, MD PhD, Cliona Grant, MD, Susan Price, RN, Seth Thacker, PhD, Abdalrahman Zarzour, Frank Pucino, PharmD, Gyorgy Csako, Cheryl Yarboro, Iain McInnes, PhD, Takashi Kuroiwa, Dimitrios Boumpas, Gabor Illei, MD, Alan T. Remaley, V. Koneti Rao, MD

Blood (2014) 124 (21): 4134.

https://doi.org/10.1182/blood.V124.21.4134.4134

Published: 2014

Journal Articles

Systematic Coronary Risk Evaluation (SCORE) Chart Identify Chronic Myeloid Leukemia Patients at Risk of Cardiovascular Diseases during Nilotinib Treatment

Massimo Breccia, MD, Matteo Molica, Irene Zacheo, Giuliana Alimena

Blood (2014) 124 (21): 4545.

https://doi.org/10.1182/blood.V124.21.4545.4545

Published: 2014

Journal Articles

Identification Of Patients (pts) With Chronic Myeloid Leukemia (CML) At High Risk Of Artery Occlusive Events (AOE) During Treatment With The 2 nd Generation Tyrosine Kinase Inhibitor (TKI) Nilotinib, Using Risk Stratification For Cardiovascular Diseases (CVD)

Delphine Rea, MD, PhD, Tristan Mirault, MD, Emmanuel Raffoux, MD, Jean-Michel Miclea, MD, Philippe Rousselot, Herve Dombret, M.D., Emmanuel Messas, MD

Blood (2013) 122 (21): 2726.

https://doi.org/10.1182/blood.V122.21.2726.2726

Published: 2013

Journal Articles

Polymorphisms at LDLR locus may be associated with coronary artery disease through modulation of coagulation factor VIII activity and independently from lipid profile

Nicola Martinelli, Domenico Girelli, Barbara Lunghi, Mirko Pinotti, Giovanna Marchetti, Giovanni Malerba, Pier Franco Pignatti, Roberto Corrocher, Oliviero Olivieri, Francesco Bernardi

Blood (2010) 116 (25): 5688–5697.

https://doi.org/10.1182/blood-2010-03-277079

Published: 2010

Includes: Supplemental data

Journal Articles

Pharmacological Resistance to Aspirin In Patients with Stable Coronary Artery Disease.

Davinder S Chadha, MD, DNB, DM, Sumana Budha, M.S, Jaya Prasad V, MBBS, Arun S. Shet, MD

Blood (2010) 116 (21): 1100.

https://doi.org/10.1182/blood.V116.21.1100.1100

Published: 2010

Journal Articles

Effect of genetic variations in platelet glycoproteins Ibα and VI on the risk for coronary heart disease events in postmenopausal women taking hormone therapy

Paul F. Bray, Timothy D. Howard, Eric Vittinghoff, David C. Sane, David M. Herrington

Blood (2006) 109 (5): 1862–1869.

https://doi.org/10.1182/blood-2006-03-013151

Published: 2006

Includes: Supplemental data

Journal Articles

Administration of Low-Dose Cyclophosphamide Reduces Progression of Atherosclerosis in Mice by Controlling the Cellular Microenvironment.

Yayoi Sato, MD, Yuichi Ohki, MD, Haruyo Akiyama, PhD, Hiroyuki Daida, MDPhD, Beate Heissig, MD, PhD, Koichi Hattori, MD, PhD

Blood (2005) 106 (11): 4452.

https://doi.org/10.1182/blood.V106.11.4452.4452

Published: 2005

Journal Articles

Framingham Score in Congenital Hemophilia Patients (HP) with Cardiovascular Disease (CVD).

Rekha Parameswaran, MD, Anne Greist, MD, Lorrie Miller-Rice, MD, Chris Roberson, Renee Murry, Matthew Sulkin, Henry Lynn, Amy Shapiro, MD

Blood (2005) 106 (11): 320.

https://doi.org/10.1182/blood.V106.11.320.320

Published: 2005

Journal Articles

Hyperhomocysteinemia and Heat Shock Proteins. Epidemiological Study in a General Population.

Elena Dulin, PhD, Maria Concepcion Guisasola, MD, PhD, Mª Mar Desco, MD, PhD, Antonio Suarez, MD, PhD, Pedro Garcia-Barreno, MD, PhD

Blood (2005) 106 (11): 4107.

https://doi.org/10.1182/blood.V106.11.4107.4107

Published: 2005

Journal Articles

Enhanced Platelet Aggregation and Thrombogenic Tendency in Adiponectin-Deficient Mice.

Hisashi Kato, Graduate Student, Hirokazu Kashiwagi, MD, Masamichi Shiraga, MD, Shigenori Honda, MD, Shigeki Miyata, MD, Junichiro Yamamoto, PhD, Yoshiyuki Kurata, MD, Tohru Funahashi, MD, Iichiro Shimomura, MD, Yoshiaki Tomiyama, MD, Yuzuru Kanakura, MD

Blood (2004) 104 (11): 800.

https://doi.org/10.1182/blood.V104.11.800.800

Published: 2004

Journal Articles

Population Analysis of a Hemophilia Treatment (HTC) for Prevalence and Outcome of Cardiovascular Disease (CVD) in Patients with Congenital Bleeding Disorders (PWBD).

Rekha Parameswaran, MD, A. Greist, MD, H. S. Lynn, PhD, C. P. Roberson, BS, J. Kirk, MD, A. D. Shapiro, MD

Blood (2004) 104 (11): 3999.

https://doi.org/10.1182/blood.V104.11.3999.3999

Published: 2004

Journal Articles

Relationships between Risk Factors for Coronary Artery Disease and Aspirin Resistance.

Kenneth A. Schwartz, MD, Dianne E. Schwartz, BS, Kimberly R. Barber, PhD, Mathew R. Reeves, PhD, Janette M. Hall, MS, Anthony C. De Franco, MD

Blood (2004) 104 (11): 1854.

https://doi.org/10.1182/blood.V104.11.1854.1854

Published: 2004

Journal Articles

Polymorphism in the fractalkine receptor CX3CR1 as a genetic risk factor for coronary artery disease

Didier Moatti, Sophie Faure, Frédéric Fumeron, Mohamed El Walid Amara, Patrick Seknadji, David H. McDermott, Patrice Debré, Marie Claude Aumont, Philip M. Murphy, Dominique de Prost, Christophe Combadière

Blood (2001) 97 (7): 1925–1928.

https://doi.org/10.1182/blood.V97.7.1925

Published: 2001

NARROW

Peripheral Blood Cytopenia and Subsequent Risk of Cardiovascular Disease and Mortality

Arterial Occlusive Events in Chronic Myeloid Leukemia Patients Treated with Ponatinib in the Real-Life Practice: Prophylaxis and Identification of Risk Factors

Hemoglobin Levels, Sex, Race and Coronary Heart Disease Risk in the Reasons for Geographic and Racial Differences in Stroke Study

Association of Comprehensive Lipoprotein Profiling with Coronary Artery Disease in Allogeneic Stem Cell Transplant (Allo-SCT) Survivors

Association of Sickle Cell Trait with Risk of Coronary Heart Disease in African Americans

Distinct Clinical, Laboratory, and Molecular Features of Myeloproliferative Neoplasm Patients Presenting with Splanchnic Vein Thrombosis

Elevated Interleukin-10 and “Disappearing HDL Syndrome” in Lymphoproliferative Disorders

Systematic Coronary Risk Evaluation (SCORE) Chart Identify Chronic Myeloid Leukemia Patients at Risk of Cardiovascular Diseases during Nilotinib Treatment

Identification Of Patients (pts) With Chronic Myeloid Leukemia (CML) At High Risk Of Artery Occlusive Events (AOE) During Treatment With The 2 nd Generation Tyrosine Kinase Inhibitor (TKI) Nilotinib, Using Risk Stratification For Cardiovascular Diseases (CVD)

Polymorphisms at LDLR locus may be associated with coronary artery disease through modulation of coagulation factor VIII activity and independently from lipid profile

Pharmacological Resistance to Aspirin In Patients with Stable Coronary Artery Disease.

Effect of genetic variations in platelet glycoproteins Ibα and VI on the risk for coronary heart disease events in postmenopausal women taking hormone therapy

Administration of Low-Dose Cyclophosphamide Reduces Progression of Atherosclerosis in Mice by Controlling the Cellular Microenvironment.

Framingham Score in Congenital Hemophilia Patients (HP) with Cardiovascular Disease (CVD).

Hyperhomocysteinemia and Heat Shock Proteins. Epidemiological Study in a General Population.

Enhanced Platelet Aggregation and Thrombogenic Tendency in Adiponectin-Deficient Mice.

Population Analysis of a Hemophilia Treatment (HTC) for Prevalence and Outcome of Cardiovascular Disease (CVD) in Patients with Congenital Bleeding Disorders (PWBD).

Relationships between Risk Factors for Coronary Artery Disease and Aspirin Resistance.

Polymorphism in the fractalkine receptor CX3CR1 as a genetic risk factor for coronary artery disease

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only